Steve Klose is an accomplished executive with extensive experience in commercial leadership within the biotechnology and life sciences sectors. Currently serving as Chief Commercial Officer at Depixus since January 2024, Klose oversees the pioneering MAGNA™ technology that enhances biomolecular interaction research. Prior to this, Klose held the role of Senior Vice President of Global Sales at RedShiftBio, where significant responsibilities included raising $20 million in Series E funding and leading global sales strategies. Klose’s career also includes impactful roles at Bio-Techne, SciKon Innovation, Quanterix, and Meso Scale Discovery, consistently demonstrating a strong capability to drive revenue growth and establish strategic partnerships with major pharmaceutical companies. Klose holds a Master of Science in Management and a Bachelor of Science in Chemistry from North Carolina State University.
This person is not in any teams
This person is not in any offices